Украинский Государственный Научно-Исследовательский Институт Реабилитации Инвалидов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Украинский Государственный Научно-Исследовательский Институт Реабилитации ИнвалидовfiledCriticalУкраинский Государственный Научно-Исследовательский Институт Реабилитации Инвалидов
Priority to UAU200812563UpriorityCriticalpatent/UA39498U/en
Publication of UA39498UpublicationCriticalpatent/UA39498U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for treating systemic lupus erythematosus comprises the use of immunosupressants, the aminoquinolone derivatives, non-steroid anti-inflammatory drugs, anticoagulants, and antiaggregants. Furthermore, Corvitin is used once a day at a dose of 0.5 for 10 days.
UAU200812563U2008-10-272008-10-27Method for treating systemic lupus erythematosus
UA39498U
(en)
use of a compound, implantable medical device, method for its manufacture, and in vitro method for exterminating, inhibiting or preventing the growth of a microbial biofilm.
Compounds derived from spiro-conjugated pyrazoles, inhibitors of ksp kinesin activity; pharmaceutical composition comprising said compound; and use of the compound for the treatment of proliferative diseases.